A Preview Of Core Laboratories's Earnings
Portfolio Pulse from Benzinga Insights
Core Laboratories (NYSE:CLB) is scheduled to release its quarterly earnings report on January 31, 2024. Analysts predict an EPS of $0.19. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, CLB's stock price has been affected more by guidance than earnings beats or misses. Last quarter, CLB met EPS estimates and saw a 1.09% stock increase the following day. Over the past year, CLB shares have decreased by 38.04%, indicating potential dissatisfaction among long-term shareholders.
January 30, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Core Laboratories is expected to report an EPS of $0.19 in its upcoming earnings. Historical data shows guidance has a significant impact on CLB's stock price. With a 38.04% decline over the past year, the earnings report could be a pivotal moment for the stock.
The short-term impact on CLB's stock price will likely hinge on whether the company beats the EPS estimate and provides positive guidance. Given the stock's sensitivity to guidance and the 38.04% decline over the past year, the earnings report could either help in recovering some losses or exacerbate the negative trend. However, the exact direction is uncertain, hence a neutral score is given.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100